[P61] ポスターセッション 61　呼吸器（ICI 有効性2）

[P61-7] KEYNOTE-A86: Phase 3 Study of 1L Subcutaneous vs Intravenous Pembrolizumab with Platinum Chemo in Metastatic NSCLC

^○Takayasu Kurata¹, Patrick Cobb², Melissa L. Johnson³, Lokesh Jain⁴, Sung Jin Kim⁴, Sanatan Saraf⁴, Mallika Lala⁴, Balazs Halmos⁵ (1.Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan, 2.St. Vincent Frontier Cancer Center, SCL Health Research Institute, Inc., Billings, MT, USA, 3.Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN, USA, 4.Merck & Co., Inc., Kenilworth, NJ, USA, 5.Department of Oncology, Montefiore Einstein Center for Cancer Care, New York, NY, USA)